Literature DB >> 24371745

Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient.

Christophe Marguet1, Loïc Favennec2, Olivier Matray2, Sébastien Bertout3, Sandrine Giraud4, Laure Couderc1, Rachid Zouhair4, Christine Leguillon1, Gilles Gargala2, Jean-J Jacques Ballet2, Jean-Philippe Bouchara5.   

Abstract

Cystic fibrosis (CF) patients are at high risk of colonization of the airways by a number of fungi, including the emerging opportunistic fungus Geosmithia argillacea. We report the eradication of respiratory G. argillacea associated with clinical resolution of severe symptoms by high-dose and prolonged micafungin therapy in a young CF patient.

Entities:  

Keywords:  Cystic fibrosis; Geosmithia argillacea; Micafungin; Pulmonary exacerbation

Year:  2012        PMID： 24371745      PMCID： PMC3854624          DOI： 10.1016/j.mmcr.2012.08.004

Source DB:  PubMed          Journal:  Med Mycol Case Rep        ISSN： 2211-7539


  10 in total

1.  Emergence of disseminated infections due to Geosmithia argillacea in patients with chronic granulomatous disease receiving long-term azole antifungal prophylaxis.

Authors:  Marie Machouart; Dea Garcia-Hermoso; Alexandre Rivier; Noura Hassouni; Emilie Catherinot; Alexandra Salmon; Anne Debourgogne; Hélène Coignard; Marc Lecuit; Marie-Elisabeth Bougnoux; Stéphane Blanche; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  Isolation of the fungus Geosmithia argillacea in sputum of people with cystic fibrosis.

Authors:  R C Barton; A M Borman; E M Johnson; J Houbraken; R P Hobson; M Denton; S P Conway; K G Brownlee; D Peckham; T W R Lee
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

3.  UNITE: a database providing web-based methods for the molecular identification of ectomycorrhizal fungi.

Authors:  Urmas Kõljalg; Karl-Henrik Larsson; Kessy Abarenkov; R Henrik Nilsson; Ian J Alexander; Ursula Eberhardt; Susanne Erland; Klaus Høiland; Rasmus Kjøller; Ellen Larsson; Taina Pennanen; Robin Sen; Andy F S Taylor; Leho Tedersoo; Trude Vrålstad; Björn M Ursing
Journal:  New Phytol       Date:  2005-06       Impact factor: 10.151

4.  Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.

Authors:  T Valentin; P Neumeister; M Pichler; A Rohn; C Koidl; D Haas; B Heiling; M Asslaber; I Zollner-Schwetz; M Hoenigl; H J F Salzer; R Krause; W Buzina
Journal:  Bone Marrow Transplant       Date:  2011-07-25       Impact factor: 5.483

5.  Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.

Authors:  Mohamed Helmi; Robert B Love; Debbie Welter; Richard D Cornwell; Keith C Meyer
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

6.  Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.

Authors:  Suk See De Ravin; Malliswari Challipalli; Victoria Anderson; Yvonne R Shea; Beatriz Marciano; Dianne Hilligoss; Martha Marquesen; Rosamma Decastro; Yen-Chun Liu; Deanna A Sutton; Brian L Wickes; Patricia L Kammeyer; Lynne Sigler; Kathleen Sullivan; Elizabeth M Kang; Harry L Malech; Steven M Holland; Adrian M Zelazny
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

7.  Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.

Authors:  Florent Morio; Delphine Horeau-Langlard; Françoise Gay-Andrieu; Jean-Philippe Talarmin; Alain Haloun; Michelle Treilhaud; Philippe Despins; Frédérique Jossic; Laurence Nourry; Isabelle Danner-Boucher; Sabine Pattier; Jean-Philippe Bouchara; Patrice Le Pape; Michel Miegeville
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

8.  Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis.

Authors:  Sandrine Giraud; Marc Pihet; Bienvenue Razafimandimby; Jacqueline Carrère; Nicolas Degand; Laurent Mely; Loïc Favennec; Eric Dannaoui; Jean-Philippe Bouchara; Alphonse Calenda
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

9.  Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.

Authors:  Françoise Symoens; Christiane Knoop; Marc Schrooyen; Olivier Denis; Marc Estenne; Nicole Nolard; Frédérique Jacobs
Journal:  J Heart Lung Transplant       Date:  2006-03-23       Impact factor: 10.247

10.  Development of an oligonucleotide array for direct detection of fungi in sputum samples from patients with cystic fibrosis.

Authors:  Jean-Phillippe Bouchara; Hsin Yi Hsieh; Sabine Croquefer; Richard Barton; Veronique Marchais; Marc Pihet; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948
  10 in total
  4 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Long-Term Rasamsonia argillacea Complex Species Colonization Revealed by PCR Amplification of Repetitive DNA Sequences in Cystic Fibrosis Patients.

Authors:  Abdelmounaim Mouhajir; Olivier Matray; Sandrine Giraud; Laurent Mély; Christophe Marguet; Isabelle Sermet-Gaudelus; Solène Le Gal; Franck Labbé; Christine Person; Françoise Troussier; Jean-Jacques Ballet; Gilles Gargala; Rachid Zouhair; Marie-Elisabeth Bougnoux; Jean-Philippe Bouchara; Loïc Favennec
Journal:  J Clin Microbiol       Date:  2016-09-07       Impact factor: 5.948

3.  Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients.

Authors:  J Steinmann; S Giraud; D Schmidt; L Sedlacek; A Hamprecht; J Houbraken; J F Meis; J P Bouchara; J Buer; P-M Rath
Journal:  New Microbes New Infect       Date:  2014-04-20

4.  The lung mycobiome: an emerging field of the human respiratory microbiome.

Authors:  Linh D N Nguyen; Eric Viscogliosi; Laurence Delhaes
Journal:  Front Microbiol       Date:  2015-02-13       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.